Article info

Authors

Fyntanidou B.
Gkarmiri S.
Grosomanidis V.
Kazakos G.
Kotzampassi K.
Kyparissa M.
Pertsikapa M.
Theodosiadis P.

DOI

The Greek E-Journal of Perioperative Medicine 2021;20(d): 47-70

PDF


Language

ΕΝ

POSTED: 12/26/21 8:10 PM
ARCHIVED AS: 2021, 2021d, Experimental Article
KEYWORDS: , ,
COMMENTS FEED: RSS 2.0

DOI: The Greek E-Journal of Perioperative Medicine 2021;20(d): 47-70

Authors: Grosomanidis V.1a, Fyntanidou B.1b*, Gkarmiri S.2b, Theodosiadis P.3c, Kazakos G.4d, Kyparissa M.1a, Pertsikapa M.2aKotzampassi K.5e

1 MD, PhD, Anesthesiology
2 MD, Anesthesiology
3 MD, MSc, PhD, Anesthesiology
4 DVM, PhD, Veterinary
5 MD, PhD, Surgery

aClinic of Anesthesiology and Intensive Care, School of Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.
bEmergency Department, AHEPA Hospital, Thessaloniki, Greece.
cAnesthesiology Department, Interbalkan Medical Center (Private Hospital) Thessaloniki, Greece.
dCompanion Animal clinic, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.
eDepartment of Surgery, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.

*Corresondence: Kautatzoglou 14A, 54639, Thessaloniki, Greece, Tel: 0030 6977427336, e-mail:

 

ABSTRACT

Increased Intraabdominal Pressure (IAP) is common in critical care patients and has detrimental effects on organs and systems. Several mechanisms and causes are involved in its pathogenesis. The aim of the present study was to investigate and record IAP effects alone and in combination with sepsis on respiratory mechanics. Sixteen male pigs were included in the study, which were randomized in two groups of 8 pigs (Group A & B). After baseline measurements, IAP increased in both groups by Helium insufflation to 25mmHg and remained elevated throughout the study period. In Group B, sepsis was induced after 60min by intravenous lipopolysaccharide (LPS) administration. Recorded parameters included PIPAW, PIPES, EIPAW, EIPES, PmeanAW, PmeanES, PEEPAW, PEEPES, CRS, CCW, CL, RinspRS, RexpRS RinspCW, RexpCW, Vexp and were measured at baseline and every 20min for 3hrs. Airway pressures in Group A (PIPAW, EIPAW, PmeanAW) increased after IAP elevation but returned to their baseline values after IAP normalization. In Group B airway pressures increased even further after LPS administration and decreased after IAP normalization but they never reached their baseline values. On the contrary esophageal pressures (PIPES, EIPES, PmeanES) showed similar alterations in both groups. PEEP did not change in any of the study groups. Respiratory system compliance decreased in both groups and returned to baseline values only in Group A. Chest wall compliance showed similar alterations in both groups. Lung compliance decreased after IAP increase in both groups and showed a further decrease after LPS administration in Group B, which remained after IAP normalization. Respiratory system inspiratory resistances increased only in Group B, whereas respiratory system expiratory resistances increased in both groups. Chest wall inspiratory resistances did not show any alterations. Our study results showed that the effects of IAP increase are reversible, whereas the effects of coexisting sepsis remain even after IAP normalization.

Abbreviations: PIPAW: Peak Inspiratory Airway Pressure (cmH2O), PIPES: Peak Inspiratory  Esophageal Pressure (cmH2O), EIPAW: End  Inspiratory Airway Pressure or (plateau pressure – Pplat) (cmH2O), EIPES: End  Inspiratory Esophageal Pressure (cmH2O), PEEP: Positive End Expiratory Pressure (cmH2O), PmeanAW: Mean Airway Pressure (cmH2O), PmeanES: Mean Esophageal Pressure (cmH2O), CRS: Compliance of the Respiratory System (ml/cmH2O), CCW: Compliance of the Chest Wall (ml/cmH2O), CL: Compliance of the Lung (ml/cmH2O), RinspRS: Inspiratory Resistances of the Respiratory System (cmH2O/L/min), RinspCW: Inspiratory Resistances of the Chest Wall (cmH2O/L/min), RexpRS: Expiratory Resistances of the Respiratory System (cmH2O/L/min), RexpCW: Expiratory Resistances of the Chest Wall (cmH2O/L/min), Vexp: Expiratory Flow (L/min).

 

Ιntroduction

Intraabdominal pressure (IAP) increase and the related Abdominal Compartment Syndrome (ACS) are common in critical care patients, are of high clinical importance and several mechanisms and causes are involved in their pathogenesis. Intraabdominal Hypertension (IAH) has detrimental effects on organs and systems both in and outside the abdominal cavity. IAH and ACS have been previously described and have been recognized as important morbidity and mortality factors in medical and surgical critically ill patients. IAH and ACS can coexist even without primary intraabdominal underlying pathology and both contribute to increased morbidity and mortality whether or not they are the cause or the result of a clinical situation.

The aim of the present study was to investigate and record IAP effects alone and in combination with sepsis on respiratory mechanics.

Intraabdominal Hypertension

The abdominal cavity could be defined as a closed compartment, partially rigid (due to the spinal column and the pelvis) and partially flexible due to the abdominal wall and the diaphragm. In a normal daily setting, IAP is affected by diaphragm and ribs movement, abdominal muscle contraction and bowel content. Therefore, IAP increases during inspiration (diaphragm contraction and downward movement) and decreases during expiration1.

IAP is normally zero (0mmHg) or slightly negative in patients with spontaneous breathing, although it can increase in obese, cirrhotic patients, in patients with ascites and in pregnant women. In patients under positive pressure ventilation IAP is slightly positive due to the transmission of the positive pleural pressure to both sides of the diaphragm2,3. After abdominal surgery, IAP ranges between 3 to 15mmHg and this increase is attributed to the postsurgical visceral edema and the abdominal wall compliance decrease because of pain4.

According to the guidelines of the World Society of the Abdominal Compartment Syndrome [WSACS] IAH is defined by a sustained or repeated pathological elevation in IAP equal to or more than 12 mmHg5-7.

Moreover, IAH is graded from I to IV based on the IAP level:

Grade I: IAP 12-15 mmHg

Grade II: IAP 16-20 mmHg

Grade III: IAP 21-25 mmHg

Grade IV: IAP>25 mmHg.

Effects of intraabdominal pressure on respiratory function

Thorax and abdomen are in a constant interaction since they are separated by the diaphragm. It has been proven in both experimental and clinical studies that a significant percentage of IAP (in average a 50%) is transmitted to the chest8. This interaction is of great clinical importance in critically ill patients in the Intensive Care Unit (ICU) and its management is a real challenge.

IAP increase pushes the diaphragm upward and causes an increase in the intrapleural and intrathoracic pressures9,10. This results in a decrease of respiratory system compliance mainly due to reduction of the chest wall compliance11.

IAP increase causes a complete deterioration of respiratory mechanics11,12 lung volume reduction and compression of the lungs. All of the respiratory pathophysiological alterations which are caused by IAP increase are directly associated with the IAP level, are reversed by IAP normalization and resemble restrictive pulmonary disease13-16.

Sepsis

Sepsis is a life threatening organ dysfunction, which is caused by a dysregulated host response to infection17,18. Sepsis can be caused both by hospital and community acquired infections. The most frequent cause of sepsis is pneumonia followed by intraabdominal and urinary tract infections19.

Sepsis has detrimental effects on several organs and systems and is a significant risk factor for ARDS.

Respiratory mechanics

Respiratory mechanics refer to the physical properties of all anatomical structures and components of the respiratory system, the related mathematical formulas and the way they change during breathing and more specifically during alterations of lung volumes and thoracic dimensions. Mechanical ventilation works by delivering flow and positive airway pressure aiming at providing a given tidal volume. Under general anesthesia and controlled mechanical ventilation (CMV), the positive airway pressure is usually applied via the endotracheal tube and is intermittent positive (IPPV)20.

Monitoring and recording of respiratory parameters (flow, pressure and volume) is considered as a necessary prerequisite for the safe and efficient achievement of all before mentioned goals but also for the study of respiratory mechanics21.

Pressures are measured by specific devices (manometers or pressure sensors) and regardless of the specific location of the measurement they are called airway pressures (PAW). In essence, pressure measurements at a specific location reflect changes per unit of time distal to the location22.

In addition to that, monitoring and recording of other pressures such as esophageal and gastric, their calculated difference and transdiaphragmatic pressures are considered useful in specialized clinical and experimental settings23-26.

Flow is measured by specific devices (flow meters) placed either in the inspiratory limb of the breathing circuit or more often in the expiratory limb. Lung volume measurement during mechanical ventilation is usually performed by using a specific formula to convert the electrical signal which flow creates27,28.

The specific location in the ventilator-lung circuit, at which measurements of respiratory mechanics are made, has an impact on measured values especially on pressure values21. Namely, measurements obtained at the airway end of the circuit (proximal airway-airway opening) reflect respiratory system mechanics (RS), measurements obtained via an esophageal catheter with a balloon (EB) reflect chest wall mechanics under MV and muscle relaxants and finally lung mechanics are calculated indirectly during ventilation21.

Diagrams of respiratory parameters (pressure-volume graphs, flow-volume graphs and pressure-flow graphs) comprise the same information, which can be also derived from the simple curves of each of the parameters per unit of time. However, diagrams allow better analysis and interpretation of clinical data due to the fact that is easy to notice and to understand the information that is displayed compared to a couple of simple waveforms. Those diagrams are the graphical display of specific mathematical equations and formulas of respiratory parameters and reflect respiratory mechanics29-31.

The pressure-volume diagram is a graphic display of the equation C=V/P (Compliance=Volume in ml / Pressure in cmH2O) and the pressure-flow diagram is a graphic display of the equation R=P/V (Resistance= Pressure in cmH2O / flow in L·sec-1)32,33.

Those two derived parameters namely compliance and resistance, which are depicted on diagrams, are calculated by the slope of the corresponding lines on the curves and are easily visualized by the shape of the waveforms21,34.

Material and Methods

This experimental study was conducted in the animal laboratory at AHEPA University Hospital Thessaloniki after obtaining the appropriate approval by the ethics committee for the use of experimental animals of the National Board on Animal Care and Use. Sixteen Landrace pigs were included in the study (age: 3 months and BW: 25kg). Animals were randomized in two groups of eight, Group A and B. After obtaining baseline measurements, IAH was induced by Helium insufflation in both groups (IAP was maintained at 25mmHg throughout the study). After 60min, sepsis was induced in Group B by intravenous lipopolysaccharide (LPS) admini stration.

Premedication, induction and maintenance of general anesthesia were identical in both groups and elective surgical tracheostomy was performed in all animals for definitive airway management. The endotracheal tube, which was used, had a diameter of 6,5mm with cuff (Portex-Blue Line HV tracheostomy tube) and the breathing circuit was elastic with rings (Taema-Air Liquide). A straight M/F 22/14 connector with a Luer Lock output was placed at the end of the Y piece of the breathing circuit and was used for the connection of the proximal airway pressure measurement (Paw) line, which was a rigid extension F/F tube.

Throughout the whole study period controlled mechanical ventilation under general anesthesia with muscle relaxants was applied. For that purpose Ceasar Ventilator, Taema-Air Liquide was used. Ventilation settings included constant inspiratory flow of 20L/min (Vinsp), inspiratory tidal volume of 10-12ml/kg BW (VTI), respiratory rate of 12-15/min (RR), Positive Endexpiratory Pressure of 5cmH2O, inspired oxygen concentration of 50% (FiO2), inspiration to expiration ratio 1:2 (TI/TE) and duration of zero flow during inspiration equal to 10% of the total inspiratory time.

IAP increase was achieved by Helium insufflation via a device used in laparoscopic surgery for pneumoperitoneum induction (Wisap, Semm System, Sauerlach Germany).

Sepsis was induced by intravenous administration 100μg/Kg LPS within 20 min, via an electronic infusion pump (ANNE, Abbott Laboratories LTD, North Chicago, IL, USA).

After initiation of general anesthesia with muscle relaxants and application of mechanical ventilation, data of respiratory parameters were obtained and recorded in real time under BTPS conditions (Body Temperature Pressure Saturated). Data was collected in the form of numerical values, simple waveforms of pressure, volume and flow per unit of time and complex diagrams of pressure-volume, pressure-flow and flow-volume.

Airway pressures, PIPAW, EIPAW and PmeanAW, were measured at the corresponding port of the Y connector and reflected respiratory system alterations.

Esophageal pressures, PIPES, EIPES and PmeanES, were measured via an esophageal balloon catheter at the Ext port of the ventilator and reflected chest wall alterations. PmeanAW, PEEPAW, PmeanES and PEEPES measurements were based on the corresponding indicators diplayed by the ventilator.

End – inspiratory pressures were measured by end inspiratory prolongation of zero flow and end – expiratory pressures were measured by end expiratory prolongation and occlusion maneuver for auto PEEP detection.

Inspiratory and expiratory flows were measured via a ventilator flow sensor by using the hot wire method.

Inspiratory (Vinsp) and expiratory volumes (Vexp) were recorded by using the exact same set up and methodology.

Minute ventilation, RR and FiO2 were recorded automatically by the ventilator.

Both the waveform and the corresponding numerical data of end expiratory carbon dioxide (ETCO2) were recorded continuously by a capnograph (Capnograph Datex).

A specific software based on the equation C = ΔV/ΔP Þ C = VTi /EIP – PEEP was used by the ventilator to record the pressure-volume diagram (Fig. 1). The slope of the line, which passes through the end- inspiratory and end – expiratory points (EIP and PEEP) on the curve was used to measure compliance (C). Respiratory system compliance was calculated based on EIPAW and PEEPAW and chest wall compliance based on EIPES και PEEPES respectively.  Lung compliance was calculated by the following equation1/CRS = 1/CCW + 1/CL. Compliance measurements were obtained at zero flow conditions and refer to the static compliance CStatic.

 

Figure 1. Pressure-Volume diagram under controlled mechanical ventilation. Paw is depicted on the horizontal axis and volume V on the vertical one. Inspiration starts at point (1), which corresponds to PEEP= =5cmH2O, continues counterclockwise and passes through point (2) which corresponds to PIP and terminates at point (3) which is EIP. The slope of the line that passes through PEEP and EIP represents compliance of the system.

 

Pressure-flow diagram [R = ΔP / ΔV] was used for resistance measurement. For inspiration, resistance was calculated by the slope of the line that passes through PIP and EIP points on the inspiratory limb of the diagram [R = (PIP – EIP) / V] and for expiration by the slope of the corresponding line on the expiratory limb of the diagram. PIPAW EIPAW and PIPES EIPES were used for respiratory system resistance RRS and chest wall resistance RCW calculations respecti-vely.

 

 

Figure 2. Pressure-flow diagram under controlled mechanical ventilation. Pressure is depicted on the horizontal axis and flow on the vertical one. Inspiration starts at point A and then at point B the maximum inspiratory flow is observed. From point B, flow starts to decrease and reaches zero at point C, which represents EIP. The line that passes through B and C represents inspiratory resistance and its slope ΔΧ: ΔΥ allows its accurate calculation. Pressure decline continues at the expiratory limb of the diagram accompanied by a negative increase of the flow until the point of maximum expiratory flow (point D). Following that, flow decreases and reaches again zero at point A, which is the point of expiratory zero flow. The line that passes through points 1 and 2 represents expiratory resistance and its slope allows its accurate calculation.

 

Vital signs were recorded throughout the study period. Heart rate and rhythm were monitored by a three-lead ECG device (Cardiocap CCI-104, Datex, Finland) and oxygen saturation by a pulse oxymeter (Cardiocap CCI-104, Datex, Finland) which was adapted on the ear flap of the animal. Continuous invasive blood pressure measurement (SAPs, SAPd, SAPm) was applied by using a femoral arterial catheter connected to a transducer (Transpac III, Abbot Laboratories LTD, North Chicago, IL, USA) which was connected to the monitor (Cardiocap CCI-104, Datex, Finland). Moreover, a catheter (Swan-Ganz, 8F, 110 cm) was placed in the pulmonary artery for hemodynamic monitoring, which included central venous pressure (CVP), right ventricular pressure (RVP), pulmonary artery pressures (PAP), pulmonary occlusion pressure (PAOP), continuous oxygenation saturation from mixed venous blood and continuous cardiac output (OptiQ SvO2/CCO Abbott Laboratories North Chicago, IL, USA).

Hemodynamic stability throughout the study period was maintained by intravenous lactated ringer administration (Ringer Lactate).

Measurements were obtained in both groups at baseline and every 20min for 180min (the final measurement was after the release of pneumo-peritoneum) (Table 1).

 

Table 1: Phases of measurement over time and corresponding study settings.

Phases of measurement Time of measurement (min) Study settings
0 0 Baseline
1 20 IAP = 25 mmHg
2 40 IAP = 25 mmHg
3 60 IAP = 25 mmHg
4 80 IAP = 25 mmHg + Sepsis in Group B
5 100 IAP = 25 mmHg + Sepsis in Group B
6 120 IAP = 25 mmHg + Sepsis in Group B
7 140 IAP = 25 mmHg + Sepsis in Group B
8 160 IAP = 25 mmHg + Sepsis in Group B
9 180 Release of the pneumoperitoneum

 

Recorded study parameters included: PIPAW, PIPES, EIPAW, EIPES, PEEP, PmeanAW, PmeanES, CRS, CCW, CL, RinspRS, RinspCW, RexpRS, RexpCW and Vexp.After the end of the study period (10 phases of measurement) ani-mals were humanely euthanized by intravenous administration of 500mg thiopental and 20ml KCl 10%.

SPSS 25 was used for the statistical data analysis. Kolmogorov-Smirnov was used to test for normal distribution and after normality was confirmed repeated measures ANOVA test was used in each group for repeated measures analysis of variance. Statistical significance was tested at the same study phases by using t test for independent samples. All p-values less than 0.05 were considered statistically significant.

RESULTS

PIPAW showed a statistically significant (p<0.01) alteration in both groups after pneumoperitoneum induction. In Group B it increased further after LPS administration and remained elevated even after pneumoperito-neum release. On the contrary in Group A it returned to its baseline values after pneumoperitoneum release (Fig. 3). A statistically significant difference (p<0.01) between the two groups was recorded only at phase 9.

 

Figure 3: PIPAW alterations during the study period.

 

PIPES showed a statistically siginificant (p<0.01) alteration in both groups after pneumoperitoneum induction and returned again to its baseline values after pneumoperitoneum release. Comparison between groups did not reveal any statistically significant difference (Fig.4).

 

Figure 4: PIPES alterations during the study period.

 

EIPAW showed a statistically significant (p<0.01) alteration in both groups after pneumoperitoneum induction. After pneumoperitoneum release it returned again to its baseline values only in Group A (Figure 5). Comparison between groups revealed statistically significant differences at Phases 7-9 (p<0.05).

 

Figure 5: EIPAW alterations during the study period.

 

EIPES showed a statistically significant (p<0.01) increase in both groups after pneumoperitoneum induction and returned again to its baseline values after pneumoperitoneum release. Comparison between groups did not reveal any statistically significant difference (Fig. 6).

 

Figure 6: EIPES alterations during the study period.

 

PmeanAW showed a statistically significant (p<0.01) increase in Group A after pneumoperitoneum induction and returned again to its baseline values after pneumoperitoneum release. In Group B it showed a further increase after phase. However, comparison between groups did not reveal a statistically significant difference (Fig. 7). PmeanES showed a statistically significant (p<0.01) increase in both groups after pneumoperitoneum induction and returned again to its baseline values after pneumoperitoneum release (Fig. 8).

 

Figure 7: PmeanAW alterations during the study period.

 

Figure 8: PmeanES alterations during the study period.

 

PEEP (both values namely at the port of the Y connector and in the esophagus) remained unchanged in both groups throughout the study period (Fig. 9 & 10).

 

Figure 9: PEEPAW alterations during the study period.

 

Figure 10: PEEPES alterations during the study period.

 

CRS showed a statistically significant (p<0.01) decrease in both groups after pneumoperitoneum induction. In Group B it decreased even further after LPS administration and never reached its baseline values. On the contrary in Group A it returned to its baseline values after pneumoperitoneum release. A statistically significant difference (0.01) between the two groups was recorded only at phase 9 (Fig. 11).

 

Figure 11: CRS alterations during the study period.

 

CCW showed a statistically significant (p<0.01) decrease in both groups after pneumoperi-toneum induction. Comparison between groups revealed a statistically significant difference at Phase 9 (p<0.05) (Fig. 12). CL showed a statistically significant (p<0.01) decrease in both groups after pneumoperitoneum induction. Comparison between groups revealed statistically significant differences, which started at phase 4 and remained until the end of the study protocol. In fact, the statistically significant differences became gradually more intense (at phases 4-8 p<0.005 and at phase 9 p<0.001) (Fig. 13). RinspRS did not show any statistically significant alterations in Group A. On the contrary, it showed a moderate increase in Group B, which reached a statistically significant level (compared to baseline values) at phases 8 & 9.

Comparison between groups revealed statistically significant differences (p<0.05) at phase 6 and thereafter until the end of the study period (Fig. 14).

 

Figure 12: CCW alterations during the study period.

 

Figure 13: CL alterations during the study period.

 

Figure 14: RinspRS alterations during the study period.

 

RexpRS showed a statistically significant (p<0,01) increase in both groups after pneumo-peritoneum induction and returned again to its baseline values after pneumoperitoneum release only in Group A. Comparison between groups revealed statistically significant differences (p<0.05) at phase 7 and thereafter until the end of the study period (Fig. 15).

 

Figure 15: RexpRS alterations during the study period.

 

RinspCW and RexpCW remained unchanged in both groups throughout the study period (Fig. 16 & 17). Vexp showed similar alterations in both groups.

It showed a statistically significant (p<0.01) increase after pneumoperitoneum induction and returned again to its baseline values after pneumoperitoneum release (Fig. 18).

 

Figure 16: RinspCW alterations during the study period. Vexp showed similar alterations in both groups.

 

Figure 17: RexpCW alterations during the study period.

 

Figure 18: Vexp alterations during the study period.

 

DISCUSSION

In this experimental study we investigated the effects of IAH and sepsis on respiratory mechanics. The combination of those two clinical conditions was selected because IAH is a cause of sepsis and on the other hand sepsis can cause an increase in IAP.

The level of IAP in our study protocol was set at 25mmHg. This was based on the reports by Malbrain et al35 who have described that IAP levels of 8-10mmHg induce important but reversible alterations. Similarly, IAP levels of 15-20mmHg have eventually the same impact12,36. An IAP value of 25mmHg is considered to be a borderline pressure value to guide the decision making for proceeding to surgical abdominal decompression10,16,37,38.

Measurements of the esophageal pressure by the use of a specific esophageal balloon catheter allowed us to study into detail mechanics of the different aspects of the respiratory system. This was even more helpful and important since sepsis was induced in one of the two study groups and esophageal pressure measurements allowed us to evaluate the impact of each factor (IAH and sepsis) individually.We documented a statistically significant increase in PIPAW right after IAH induction (IAP=25mmHg), which was actually doubled compared to baseline. This trend remained throughout the study period and was fully restored only in Group A after pneumoperitoneum release. Sepsis induction in Group B increased PIPAW even further. However, there was no statistically significant difference between the two study groups.

Alterations of PIPAW measured at the port of the Y connector reflect the effects of increased IAP on the respiratory system mechanics.

Several experimental and clinical studies found that elevation of IAP causes increase of intrapleural and airway pressures 9,10 and results in complete respiratory function deterioration in patients with spontaneous ventilation and under mechanical ventilation39,40.

PIPES showed a similar statistically significant increase compared to baseline, which was recorded after IAH induction and was fully restored after pneumoperitoneum release in both groups. Those findings have been also confirmed by other investigators12.

PIPES measurements were obtained by a specific set up in the esophagus and reflected alterations of respiratory mechanics, which were associated with the chest wall40-43 . This impact is attributed to IAP transmission to the chest wall and diaphragm translocation. At this point it should be noticed, that sepsis induction does not have any impact on chest wall mechanics since its negative effects are associated with the lungs and not with the chest wall12,35,36. This finding should be taken into account when managing ARDS patients, where treatment decisions should be guided and modified according to the underlying pathology, the clinical condition and the role of the abdomen in the pathogenesis pathway12.

EIPAW reflects alterations associated with the respiratory system under static end – inspiratory conditions. It should be mentioned that in this specific measurement set up, EIPAW reflects relatively accurately the corresponding alveolar pressures44.

In this study model, EIPAW showed a statistically significant increase in both groups (it was doubled compared to baseline) immediately after IAP increase but returned to baseline values after pneumoperitoneum release only in Group A.

Actually, these alterations reflect the impact of increased IAP on the elastic lung properties, which clinically are presented as respiratory deterioration or failure in IAH patients39. Sepsis induction in Group B caused a further EIPAW increase, which was not restored after pneumoperitoneum release. This could be explained by the assumption that sepsis caused a permanent change on lung mechanics

On the other hand EIPES showed in both groups changes similar to the previously mentioned PIPes alterations, which confirm the impact of pneumoperitoneum on chest wall mechanics and at the same time the absence of any sepsis effect on chest wall mechanics12,35,36.

PmeanAW is a derivative parameter and as such it is dependent on the evolution of pressures over time at each breathing cycle. Thereafter, PmeanAW alterations reflect the already described and discussed changes in both groups45,46.

To be more specific, PmeanAW increased in a statistically significant manner in Group A after pneumoperitoneum induction and was fully restored after its release. In Group B, PmeanAW showed a statistically significant increase after pneumoperitoneum induction but did not return to baseline values after IAP normalization. These alterations are explained by the corresponding PIPAW and EIPAW changes. PmeanAW reflects mean alveolar pressure40,45,46.

PmeanES was measured by the esophageal balloon catheter. PmeanES alterations confirmed the findings which were made by PIPES and EIPES changes. Namely, it was found that PmeanES is affected only by increased IAP. PmeanES and its alterations in a setting of increased IAP conditions are possibly of great importance especially in patients with the corresponding underlying pathology due to the impact of positive pressures on the cardiovascular system and on pulmonary microcirculation39.

PEEP did not show any changes in any of the two groups throughout the study period at both measurement points, namely at the port of the Y connector and in the esophagus. In the setting of controlled mechanical ventilation, PEEP is a predetermined parameter that remains constant provided that no dynamic hyperinflation occurs, which could lead to air trapping and auto positive end – expiratory PEEP (auto PEEP)47.

During the application of occlusion maneuver (occlusion of the expiratory limb of the breathing circuit and suspension of the next insufflation) no auto PEEP was detected at any case in our study.

Study of the respiratory system compliance (CRS) (Fig. 1), as this was calculated by the corresponding graphs and waveforms, clearly depicted the impact of increased IAP and sepsis on the whole respiratory system.  It should be noted that CRS describes the elastic properties of the whole respiratory system, including the lungs and the chest wall and therefore those parameters are both taken into account when calculating CRS48. In Group A, CRS showed a statistically significant decrease during pneumoperitoneum and was restored after its release. On the other hand, in Group B, CRS did not return to baseline values after pneumoperitoneum release. This is explained due to the fact that CRS reflects mechanics both of the chest wall and of the lungs.

CCW decreased in a statistically significant manner in both groups right after pneumoperitoneum induction. This dramatic decrease is attributed to the increase of chest wall elasticity because of the cranial translocation of the diaphragm and the direct transmission of IAP to the thoracic cavity11. After pneumoperitoneum release CCW returned to baseline values in both groups. Sepsis did not have any additional effect on CCW.

In the present study CL is a derivative parameter and as such it is depended on CRS and CCW measurements. This specific methodology is considered compulsory in the setting of controlled mechanical ventilation and allows simultaneous measurements41. IAP increase had a negative effect on CL in Group A, which is explained by the fact that lungs and chest wall are connected in parallel. Lungs are included in the thoracic cavity and therefore they are subjected to the before mentioned effects, which refer to the chest wall12,36.

In Group B, sepsis had a negative impact on lung compliance immediately after the first minutes of LPS administration. Those negative effects were more intense in Group B compared to Group A and remained even after pneumoperitoneum release. This is probably attributed to the impact of sepsis on lung parenchyma, which includes pulmonary hypertension, total lung water increase and the subsequent effects on mechanics.

In a setting of combined ACS and sepsis, we can presume that both the alterations on the chest wall due to abdominal distension and on the lung parenchyma due to the autonomic ne-gative effects of sepsis contribute to the decreased compliance.

Malbrain et al reported similar findings and pointed out that those effects can be reversed by application of positive endexpiratory pressure, which results in airway pressure increase35. In an effort to titrate the necessary PEEP, Malbrain et al discovered the relationship between level of IAP and necessary PEEP. Despite the fact that this maneuver might seem opposed to consensus statements, it is demonstrated that it could be necessary and clinically useful. The rationale behind this maneuver is that PEEP can provide protection to lung parenchyma against extrathoracic damaging factors. Therefore, PEEP application in patients with ACS, along with other indicated interventions could be considered as an alternative treatment option for the management of respiratory system disorders and compliance restoration49.

Clinical management of this particular respiratory system pathophysiology presents huge challenges and cannot be treated just by IAP release or PEEP application12,36,50.

RinsRS did not show any significant evolution in Group A, whereas RinsRS showed an increase in Group B, which became statistically significant after phase 6. Moreover, in Group B, RinsRS did not return to baseline values at the end of the study period. These findings can be attributed to resistance increase of the distal airways due to the effects of sepsis on the bronchial smooth muscles by bronchoconstriction and to lung parenchyma disorders and altered lung mechanics52,53.

During expiration RexpRS increased statistically significant in both groups. In Group A, RexpRS returned to baseline values after pneumoperitoneum release, whereas in Group B RexpRS remained increased in a statistically significant manner compared to Group A. RexpRS increase in the setting of IAH can be explained by the before mentioned rise of expiratory flow, since flow is being taken into account when calculating RexpRS54. On the contrary, the more intense increase of RexpRS in Group B and the fact that RexpRS did not return to baseline values can be attributed to the before mentioned disorders, which are associated with the lung parenchyma55.As far as chest wall resistances are concerned, there were no statistically significant findings neither during inspiration nor during expiration in any of the two groups.

In the present study, Vexp evaluation was considered necessary due to the fact that increased IAP facilitates expiration, which is a passive process even under controlled mechanical ventilation56. This assumption was confirmed in our study since we observed in both groups a statistically significant Vexp increase compared to baseline, which was restored in Group A after pneumoperitoneum release. In Group B, Vexp did not return to baseline values at the end of the study period. These findings have not been properly and adequately described in the literature expect some scarce reports of patients with severe obstructive lung disease, who were managed effectively regarding expiration by intermittent application of abdominal or chest compressions57-59.

The limitations in this experimental study concerned the use of pigs as experimental models in which the increase of the IAP was induced by insufflation into the peritoneal cavity and sepsis by intravenous LPS administration. Despite the fact that the methods used for the IAP increase and sepsis induction are considered as acceptable experimental models, it should be noted that the associated underlying pathology, which in clinical practice causes IAH, sepsis or both, was not present. Moreover, it would be useful to study a third group of septic pigs without IAH to investigate and determine the isolated effects of sepsis on respiratory mechanics.

Conclusion

IAP increase has detrimental effects on respiratory system mechanics. Those effects are reversible after IAP normalization. The coexistence of sepsis with IAH causes further adverse effects, which remain even after IAP normalization.


Addittional materials: No


Acknowledgements:

Not applicable

Authors’ contributions:

GV drafted the paper and is the lead author. FB contributed to planning and the critical revision of the paper. GS contributed to planning and the critical revision of the paper. ThP contributed to planning and the critical revision of the paper. KG contributed to planning and the critical revision of the paper. KM contributed to planning and the critical revision of the paper. PM contributed to planning and the critical revision of the paper. KK contributed to planning and the critical revision of the paper.

Funding: Not applicable.

Availability of supporting data:

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Ethical approval and consent to participate:

No IRB approval required.

Competing interests:

The authors declare that they have no competing interests.

Received: December 2021, Accepted: December 2021, Published: December 2021.


REFERENCES

  1. Overholt R. Intraperitoneal pressure. Arch Surg 1931; 22 : 691–703.
  2. Cheatham M. Intra–abdominal hypertension and abdominal compartment syndrome. New Horizons 1999; 7: 96 – 115.
  3. Schein M, Wittmann D, Aprahamian C, et al. The abdominal compartment syndrome: The physiological and clinical consequences of elevated intra – abdominal pressure. J Am Coll Surg 1995; 180:845 – 53.
  4. Kron I, Harman K, Nolan S. The measurement of intra – abdominal pressure as a criterion for abdominal re–exploration. Ann Surg 1984; 199:28 – 30.
  5. Kirkpatrick A, Roberts D, De Waele J, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med 2013; 39:1190–1206.
  6. Malbrain M, Cheatham ML, Kirkpatrick A, et al. Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome I. Definitions. Intensive Care Med 2006; 32: 1722–32.
  7. Malbrain M, Cheatham ML, Kirkpatrick A, et al. Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome II. Intensive Care Med 2007; 33: 951–62.
  8. Malbrain M, Cheatham M. Cardiovascular effects and optimal preload markers in intra-abdominal hypertension. In: Vincent J-L, editor. Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer-Verlag; 2004. p. 519–43.
  9. Malbrain Μ. Respiratory effects of increased intra-abdominal pressure. Réanimation 2007; 16: 49–60.
  10. Cullen D, Coyle J, Teplick R, et al. Cardiovascular, pulmonary, and renal effects of massively increased intra–abdominal pressure in critically ill patients. Crit Care Med 1989;17:118 – 21
  11. Mutoh T, Lamm WJ, Embree LJ, et al. Abdominal distension alters regional pleural pressures and chest wall mechanics in pigs in vivo. J Appl Physiol 1991; 70: 2611–8.
  12. Ranieri V, Brienza N, Santostasi S, et al. Impairment of lung and chest wall mechanics in patients with acute respiratory distress syndrome: role of abdominal distension. Am J Respir Crit Care Med. 1997; 156:1082–91.
  13. Regli A, Pelosi P, Malbrain M. Ventilation in patients with intra abdominal hypertension: what every critical care physician needs to know. Intensive Care 2019;9: 52.
  14. Pelosi P, Quintel M, Malbrain ML. Effect of intra-abdominal pressure on respiratory mechanics. Acta Clin Belg. 2007;62: 78–88.
  15. Pelosi P, Brazzi L, Gattinoni L. Measuring intra – abdominal pressure in the intensive care setting. In: Vincent J (ed) Yearbook of intensive care and emergency medicine. Springer Berlin 2001: 586 – 95.
  16. Malbrain M. Intra–abdominal pressure in the intensive care unit: clinical tool or toy? In: Vincent J (ed) Yearbook of intensive care and emergency medicine. Springer Berlin 2001 pp 547 – 85.
  17. Singer M, Deutschman CS, Seymour CW, et al: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:801–810.
  18. Shankar-Hari M, Phillips GS, Levy ML, et al. Sepsis Definitions Task Force: Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:775–787.
  19. Angus D, Tom van der Poll T. Severe Sepsis and Septic Shock. N Engl J Med 2013;369: 840-51.
  20. Dhand R. Ventilator Graphics and Respiratory Mechanics in the Patient With Obstructive Lung Disease. Respir Care 2005;50: 246 –59.
  21. Σέτζης Δ. Συνεχής παρακολούθηση και καταγραφή των αναπνευστικών παραμέτρων κατά τον μηχανικό αερισμό. Απόπειρα εισαγωγής στην γραφική ανάλυση. Θέματα Αναισθησιολογίας και Εντατικής Ιατρικής 1997; 7: 73 – 93.
  22. Gallagher C. Measurement of respiratory pressures. In: Tobin M (ed) Principles and Practice of Intensive Care Monitoring. McGraw–Hill, New York 1998, pp 81 – 90.
  23. Jubran A. Monitoring patient mechanics during mechanical ventilation. Criti Care Clin 1998; 14: 629 – 53.
  24. Higgs B, Bechrakis P, Bevan D, et al. Measurement of pleural pressure with esophageal balloon in humans. Anesthesiology 1983; 59: 340 – 43.
  25. Zin W. Milic – Emili J. Esophageal pressure measurement. In: Tobin M (ed) Principles and Practice of Intensive Care Monitoring. McGraw–Hill, New York 1998, pp 544 – 52.
  26. Yoshida T, Brochard L. Esophageal pressure monitoring: why, when and how? Curr Opin Crit Care 2018; 24: 1-7.
  27. O’ Donnell D, Webb K. Measurement of respiratory flow and volume. In: Tobin M (ed): Principles and Practice of Intensive Care Monitoring. McGraw–Hill, New York 1998, pp 63 – 80.
  28. Tobin M. Monitoring of pressure, flow and volume during mechanical ventilation. Resp Care 1992; 37: 1081 – 95.
  29. Marini J. Monitoring during mechanical ventilation. Clin Chest Med 1988; 9: 73–100.
  30. Matamis D, Lemaire F, Harf A, et al. Total respiratory pressure–volume curves in the adult respiratory distress syndrome. Chest 1984; 86:58–66.
  31. Rossi A, Polese G, Milic–Emili J: Monitoring respiratory mechanics in ventilator–dependent patients. In Tobin M (ed) Principles and Practice of Intensive Care Monitoring. McGraw–Hill, New York 1998, pp 553 – 96.
  32. Brochard L. Respiratory pressure – volume curves. In: Tobin M (ed) Principles and Practice of Intensive Care Monitoring. McGraw–Hill, New York, 1998, pp 597 – 616.
  33. Stenqvist O. Practical assessment of respiratory mechanics. Br J Anaesth 2003; 91: 92 -105.
  34. Lu Q, Vieira S, Richecoeur J, et al. A simple automated method for measuring pressure–volume curves during mechanical ventilation. Am J Respir Crit Care Med 1999; 159: 275 – 82.
  35. Malbrain M, Bakajika D. Effects of abdominal compression and decompression on cardiovascular and respiratory function. Intensive Care Med 1999; 25 (suppl 1): S 22.
  36. Rossi A, Bricchi C, Mergoni M. Lung mechanics in ARDS. In: Vincent J, ed. Yearbook of intensive care and emergency medicine. Springer, Berlin 1999, p 3 – 17.
  37. Burch J, Moore E, Moore F, et al. The abdominal compartment syndrome. Surg Clin North Am 1996; 76: 833 – 42.
  38. Malbrain M. Abdominal pressure in the critically ill. Curr Opinion in Crit Care 2000; 17 – 29.
  39. Richardson D, Trinkle K. Hemodynamic and respiratory alterations with increased intra – abdominal pressure. J Surg Res 1976; 20: 401 – 404.
  40. Grosomanidis V. The abdominal compartment syndrome: Effects on the cardiovascular and respiratory systems. Thesis (Aristotle University of Thessaloniki) Ref No1539; 28/2/2003.
  41. D’Angelo E, Calderini E, Torri G, et al. Respiratory mechanics in anesthetized paralyzed humans: Effects of flow, volume, and time. J Appl Physiol 1989; 67: 2556 – 64.
  42. Akoumianaki E, Maggiore S, Valenza F, et al. The application of esophageal pressure measurement in patients with respiratory failure. Am J Respir Crit Care Med 2014;189 :520–31.
  43. Brochard L. Measurement of esophageal pressure at bedside: pros and cons. Curr Opin Crit Care 2014, 20:39–46.
  44. Hendersona w, William Sheelb w. Pulmonary mechanics during mechanical ventilation. Respiratory Physiology & Neurobiology 2012; 180: 162– 72.
  45. Marini J, Ravenscraft S. Mean airway pressure: physiologic determinants and clin- ical importance –Part 1: physiologic determinants and measurements. Crit Care Med 1992;20: 1461–72.
  46. Marini J, Ravenscraft S. Mean airway pressure: physiologic determinants and clinical importance–Part 2: Clinical implications. Crit Care Med 1992; 20: 1604-16.
  47. Hess D. Respiratory mechanics in mechanically ventilated patients. Respir Care 2014; 59: 1773–94.
  48. Harris RS. Pressure-Volume Curves of the Respiratory System. Respir Care 2005; 50: 78 –98.
  49. Regli Α, Pelosi P, Malbrain M. Ventilation in patients with intra abdominal hypertension: what every critical care physician needs to know. Intensive Care 2019; 52:1 – 19.
  50. De Laet Ι, Malbrain Μ, De Waele J. Clinician’s Guide to Management of Intraabdominal Hypertension and Abdominal Compartment Syndrome in Critically Ill Patients. Critical Care 2020; 24: 1-9.
  51. Dhand R. Ventilator Graphics and Respiratory Mechanics in the Patient With Obstructive Lung Disease. Respir Care 2005;50: 246 –59.
  52. Kaminsky D. What Does Airway Resistance Tell Us About Lung Function? Respir Care 2012;57: 85–96.
  53. Dexter A, Clark K. Ventilator Graphics: Scalars, Loops, & Secondary Measures. Respir Care 2020;65: 739–59.
  54. Hamahata N, Sato R, Daoud E. Go with the flow—clinical importance of flow curves during mechanical ventilation: A narrative review. Can J Respir Ther 2020;56:11–20
  55. Restrepo R, Serrato D, Adasme R. Assessing respiratory system mechanical function. Clin Chest Med 2016; 37: 615–32.
  56. Lumb AB. Nunn’s applied respiratory physiology. 5th ed. Butterworths; 2000. p. 114–22.
  57. Marini J, Gattinoni L. Improving lung compliance by external compression of the chest wall. Crit Care 2021; 25:264.
  58. Kummer R, Shapiro R, Marini JJ, et ai. Paradoxically improved respiratory compliance with abdominal compression in COVID ARDS. 2021; 160: 1739 – 1742.
  59. Lemyze M, Favory R, Alves I et al. Manual compression of the abdomen to assess expiratory flow limitation during mechanical ventilation. J Crit Care. 2012; 27: 37–44.

 

Publisher’s Note

The publisher remains neutral with regard to jurisdictional claims in published maps and institutional afliations.

Citation: Grosomanidis V, Fyntanidou B, Gkarmiri S, Theodosiadis P, Kazakos G , Kyparissa M, Pertsikapa M, Kotzampassi K. Respiratory mechanics in a porcine model of abdominal hypertension with or without sepsis. Greek e j Perioper Med. 2021;20 (d):47-70.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution – ShareAlike 4.0 International license (CC BY-SA 4.0) (https://creativecommons.org/licenses/by-sa/4.0/)

Language
Αναβάθμιση του Impact Factor

Archives
ATOM Feed
RSS Feed
RDF Feed
Creative Commons License